Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.26.3 (
RNase III
)
1,015
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
RNase III
is a double-stranded RNA-specific endoribonuclease that processes and degrades numerous mRNA molecules in Escherichia coli. A previous genome-wide analysis of E. coli transcripts showed that steady-state levels of mltD mRNA, which encodes
membrane-bound
lytic murein transglycosylase D, was most affected by changes in cellular concentration of
RNase III
. Consistent with this observation, in vitro and in vivo analyses of mltD mRNA revealed
RNase III
cleavage sites in the coding region of mltD mRNA. Introduction of a nucleotide substitution at the identified
RNase III
cleavage sites inhibited
RNase III
cleavage activity on mltD mRNA, resulting in, consequently, approximately two-fold increase in the steady-state level of the mRNA. These findings reveal an
RNase III
-mediated regulatory pathway that modulates mltD expression in E. coli.
...
PMID:RNase III controls mltD mRNA degradation in Escherichia coli. 2434 75